These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7295339)

  • 61. Induction of hepatic cytosolic fatty acid binding protein with clofibrate accelerates both membrane and cytoplasmic transport of palmitate.
    Luxon BA; Milliano MT; Weisiger RA
    Biochim Biophys Acta; 2000 Sep; 1487(2-3):309-18. PubMed ID: 11018482
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats.
    Ringseis R; Pösel S; Hirche F; Eder K
    Pharmacol Res; 2007 Aug; 56(2):175-83. PubMed ID: 17644405
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of the antilipolytic compound acipimox on peroxisome marker enzymes, lipid pattern and biotransformation related functions in rat liver.
    Orsini G; Lovisolo PP; Chiari A; Branzoli U
    Pharmacol Res Commun; 1985 Oct; 17(10):927-36. PubMed ID: 4070342
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of Wy-14,643 on cholesterol metabolism in normal and hypercholesterolemic rats.
    Tomarelli RM; Bauman LM; Savini S
    Atherosclerosis; 1978 Aug; 30(4):301-11. PubMed ID: 708488
    [No Abstract]   [Full Text] [Related]  

  • 65. Presence and features of fatty acyl-CoA binding activity in rat hepatic peroxisomes.
    Hashimoto F; Hayashi H
    J Biochem; 2002 Mar; 131(3):453-60. PubMed ID: 11872175
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The hypolipidemic peroxisome-proliferating drug, bis(carboxymethylthio)-1.10 decane, a dicarboxylic metabolite of tiadenol, is activated to an acylcoenzyme A thioester.
    Aarsland A; Berge RK; Bremer J; Aarsaether N
    Biochim Biophys Acta; 1990 Feb; 1033(2):176-83. PubMed ID: 2306462
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preventive effects of dehydroepiandrosterone acetate on the fatty liver induced by orotic acid in male rats.
    Goto H; Yamashita S; Makita T
    Exp Anim; 1998 Oct; 47(4):257-60. PubMed ID: 10067169
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of the peroxisome proliferator-activated receptor-alpha agonists clofibrate and fish oil on hepatic fatty acid metabolism in weaned dairy calves.
    Litherland NB; Bionaz M; Wallace RL; Loor JJ; Drackley JK
    J Dairy Sci; 2010 Jun; 93(6):2404-18. PubMed ID: 20494149
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Studies on the hepatomegaly caused by the hypolipidemic drugs nafenopin and clofibrate.
    Beckett RB; Weiss R; Stitzel RE; Cenedella RJ
    Toxicol Appl Pharmacol; 1972 Sep; 23(1):42-53. PubMed ID: 5071041
    [No Abstract]   [Full Text] [Related]  

  • 70. Subcellular distribution of alkyl dihydroxyacetone phosphate synthase in rat liver.
    Shinojima K; Ono T; Ishibashi T; Okayasu T; Imai Y
    Hokkaido Igaku Zasshi; 1981 May; 56(3):309-17. PubMed ID: 7319454
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of clofibrate treatment on carnitine acyltransferases in different subcellular fractions of rat liver.
    Kahonen MT
    Biochim Biophys Acta; 1976 May; 428(3):690-701. PubMed ID: 1276175
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of clofibrate on the intracellular localization of palmitoyl-CoA hydrolase and palmitoyl-L-carnitine hydrolase in rat liver.
    Berge RK; Skrede S; Farstad M
    FEBS Lett; 1981 Feb; 124(1):43-7. PubMed ID: 6111472
    [No Abstract]   [Full Text] [Related]  

  • 73. Differential effects of dehydroepiandrosterone and clofibrate on the binding of 7,12-dimethyl benz(a)anthracene to hepatic DNA in vivo--a preliminary study.
    Prasanna HR; Hart RW; Magee PN
    Drug Chem Toxicol; 1989; 12(3-4):327-35. PubMed ID: 2534380
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Effect of clofibrate on intracellular enzyme distribution in the rat liver].
    Panchenko LF; Popova SV; Pirozhkov SV; Antonenkov VD
    Tsitologiia; 1983 Nov; 25(11):1302-8. PubMed ID: 6659071
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of clofibrate on the handling of dietary and liver fat.
    Westerfeld WW; Elwood JC; Richert DA
    Biochem Pharmacol; 1972 Apr; 21(8):1117-25. PubMed ID: 5034197
    [No Abstract]   [Full Text] [Related]  

  • 76. Effect of clofibrate on DNA synthesis in rat liver and kidney.
    Seifert J; Mostecká H
    Arch Toxicol; 1987; 60(1-3):131-2. PubMed ID: 3619635
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of soybean phospholipid, chlorella phospholipid, and clofibrate on collagen and elastin synthesis in the aorta and on the serum and liver lipid contents in rats.
    Hashimoto S; Setoyama T; Yokokura T; Mutai M
    Exp Mol Pathol; 1982 Feb; 36(1):99-106. PubMed ID: 7198996
    [No Abstract]   [Full Text] [Related]  

  • 78. Studies on fatty acid-binding proteins. The diurnal variation shown by rat liver fatty acid-binding protein.
    Wilkinson TC; Wilton DC
    Biochem J; 1987 Mar; 242(3):913-7. PubMed ID: 3593284
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum lipid-lowering properties of 6-chloro-9-[2-(6-methyl-3-pyridyl)ethyl]-1,2,3,4-tetrahydrocarbazole-2-carboxylic acid.
    Dalton C; Pool WR
    J Pharm Sci; 1977 Mar; 66(3):348-52. PubMed ID: 845800
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Concomitant increase by peroxisome proliferators of fatty acid-binding protein, peroxisomal beta-oxidation and cytosolic acyl-CoA hydrolase in liver.
    Katoh H; Kawashima Y; Takegishi M; Watanuki H; Hirose A; Kozuka H
    Res Commun Chem Pathol Pharmacol; 1985 Aug; 49(2):229-41. PubMed ID: 2865776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.